Article
Molecular model for neuroendocrine prostate cancer progression
23 Mar 2018
Abstract excerpt
Prostate cancer (PCa) is the most common form of cancer in men in the developed world and the second leading cause of cancer-related deaths. While advanced PCa is initially controlled with hormonal therapies targeting the androgen receptor (AR) pathway, recurrence occurs because of the emergence of lethal castration-resistant PCa (CRPC). Despite newer AR pathway inhibitors that prolong survival, resistance still...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
